Profile
RNXT VRTX REGN VRNA ARGX ALNY
Company Name RenovoRx, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $35.55M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.01K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Shaun R. Bagai Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
RNXT VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
RNXT VRTX REGN VRNA ARGX ALNY
Last Close $0.8041 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $1.54 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.75 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -47.79 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 7.21 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
RNXT VRTX REGN VRNA ARGX ALNY
1 Month Return -28.21 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -14.46 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -31.86 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -23.42 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -37.67 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -27.56 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
RNXT VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -741.64 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
RNXT VRTX REGN VRNA ARGX ALNY
Asset Growth 453.75 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth - 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth 3.74 % 9.09 % -131.37 % 24.59 %
Net Income Growth 13.86 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share -5.5 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -68.49 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -68.49 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 3.74 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 11.05 % - -143.33 % -107.98 %
Operating 3 Year CFG -16.75 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -99.9 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -99.9 % -100 % 40.15 % 97.08 %
EPS Growth 26 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 26 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 230.14 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -77.92 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 124.32 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 124.32 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth - 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 10.93 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
RNXT VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 67.78 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -99.1 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -122.19 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -124.65 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 95.57 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -1252.16 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -4399.58 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 5.49 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.34 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM 1.1 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 410.62 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 8.28 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.28 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.28 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 27.41 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -1118.86 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.13 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -4399.58 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -3.42 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -3.42 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -3.42 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
RNXT VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 100% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.01B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.01B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -0.37 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
RNXT VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.01B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
RNXT VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.6
AARD Aardvark Therapeutics, Inc. Common Stock 12.67
ABCL AbCellera Biologics Inc. 3.135
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.06
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.56
ABPWW 0.0133
ABSI Absci Corporation 2.6
ABUS Arbutus Biopharma Corporation 4.16
ABVC ABVC BioPharma, Inc. 1.73
ABVX Abivax SA American Depositary Shares 122.77
ACAD ACADIA Pharmaceuticals Inc. 22.47
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.81
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.28
ACIU AC Immune SA 3.03
ETFs With Exposure to RNXT
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00004 341.47
VXF Vanguard Extended Market Index Fund 0.00038 218.1
IWC iShares Micro-Cap ETF 0.00269 168.25
VUN.TO Vanguard U.S. Total Market Index ETF 0.00004 126.01
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00004 118.61
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00004 52.53
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00004 52.52
VBINX Vanguard Balanced Index Fund Investor Shares 0.00004 52.53
VGRO.TO Vanguard Growth ETF Portfolio 0.00002 44.38
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00002 55.86
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.88
VCNS.TO Vanguard Conservative ETF Portfolio 0.00001 32.13
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.34
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.99
VTSAX Vanguard Total Stock Market Index Fund 0.00004 166.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00038 165.55
VITSX Vanguard Total Stock Market Index Fund 0.00004 166.27
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000244559 16.69
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00038 165.56
VTS.AX Vanguard US Total Market Shares Index ETF 0.00004 481.52
VEMPX Vanguard Extended Market Index InstlPlus 0.00038 408.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00004 311.9
Unlock